Min Son of Hanol IP & Law explains how the timing of a claim for novelty affects the procurement or enforceability of design rights after a ruling on a case with a surprising twist
Min Son of Hanol IP & Law finds encouragement for developers of new chemical entity drugs after the rulings handed down in a battle between AstraZeneca and several generic pharmaceutical companies
Virtual world platforms have created opportunities for brand owners and led to changes to the Trademark Act in South Korea, reports Min Son of Hanol IP & Law
Min Son of Hanol IP & Law reports on a ruling by the Supreme Court of Korea that will make it easier to obtain polymorph patents of known chemicals in the country
